Global In-Vitro Diagnostics Industry Growth and Trends Forecast to 2031
Description
Summary
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
According to APO Research, The global In-Vitro Diagnostics market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for In-Vitro Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for In-Vitro Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for In-Vitro Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostics.
The In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
In-Vitro Diagnostics Segment by Company
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
JNJ
Sysmex
KHB
DaAn Gene
Leadman
BioSino
BSBE
Maccura
In-Vitro Diagnostics Segment by Type
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other
In-Vitro Diagnostics Segment by Application
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
In-Vitro Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of In-Vitro Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.
According to APO Research, The global In-Vitro Diagnostics market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for In-Vitro Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for In-Vitro Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for In-Vitro Diagnostics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Diagnostics.
The In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
In-Vitro Diagnostics Segment by Company
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
JNJ
Sysmex
KHB
DaAn Gene
Leadman
BioSino
BSBE
Maccura
In-Vitro Diagnostics Segment by Type
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other
In-Vitro Diagnostics Segment by Application
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
In-Vitro Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of In-Vitro Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
111 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global In-Vitro Diagnostics Market Size Overview by Region 2020 VS 2024 VS 2031
- 1.4 Global In-Vitro Diagnostics Market Size by Region (2020-2031)
- 1.4.1 Global In-Vitro Diagnostics Market Size by Region (2020-2025)
- 1.4.2 Global In-Vitro Diagnostics Market Size by Region (2026-2031)
- 1.5 Key Regions In-Vitro Diagnostics Market Size (2020-2031)
- 1.5.1 North America In-Vitro Diagnostics Market Size Growth Rate (2020-2031)
- 1.5.2 Europe In-Vitro Diagnostics Market Size Growth Rate (2020-2031)
- 1.5.3 Asia-Pacific In-Vitro Diagnostics Market Size Growth Rate (2020-2031)
- 1.5.4 South America In-Vitro Diagnostics Market Size Growth Rate (2020-2031)
- 1.5.5 Middle East & Africa In-Vitro Diagnostics Market Size Growth Rate (2020-2031)
- 2 In-Vitro Diagnostics Market by Type
- 2.1 Type Introduction
- 2.1.1 Tissue Diagnostics
- 2.1.2 Professional Diagnostic
- 2.1.3 Molecular Diagnostic
- 2.1.4 Diabetes Monitoring
- 2.1.5 Other
- 2.2 Global In-Vitro Diagnostics Market Size by Type
- 2.2.1 Global In-Vitro Diagnostics Market Size Overview by Type (2020-2031)
- 2.2.2 Global In-Vitro Diagnostics Historic Market Size Review by Type (2020-2025)
- 2.2.3 Global In-Vitro Diagnostics Market Size Forecasted by Type (2026-2031)
- 2.3 Global In-Vitro Diagnostics Market Size by Regions
- 2.3.1 North America In-Vitro Diagnostics Market Size Breakdown by Type (2020-2025)
- 2.3.2 Europe In-Vitro Diagnostics Market Size Breakdown by Type (2020-2025)
- 2.3.3 Asia-Pacific In-Vitro Diagnostics Market Size Breakdown by Type (2020-2025)
- 2.3.4 South America In-Vitro Diagnostics Market Size Breakdown by Type (2020-2025)
- 2.3.5 Middle East and Africa In-Vitro Diagnostics Market Size Breakdown by Type (2020-2025)
- 3 In-Vitro Diagnostics Market by Application
- 3.1 Type Introduction
- 3.1.1 Diabetes
- 3.1.2 Infectious Diseases
- 3.1.3 Oncology
- 3.1.4 Cardiology
- 3.1.5 HIV
- 3.1.6 Other
- 3.2 Global In-Vitro Diagnostics Market Size by Application
- 3.2.1 Global In-Vitro Diagnostics Market Size Overview by Application (2020-2031)
- 3.2.2 Global In-Vitro Diagnostics Historic Market Size Review by Application (2020-2025)
- 3.2.3 Global In-Vitro Diagnostics Market Size Forecasted by Application (2026-2031)
- 3.3 Global In-Vitro Diagnostics Market Size by Regions
- 3.3.1 North America In-Vitro Diagnostics Market Size Breakdown by Application (2020-2025)
- 3.3.2 Europe In-Vitro Diagnostics Market Size Breakdown by Application (2020-2025)
- 3.3.3 Asia-Pacific In-Vitro Diagnostics Market Size Breakdown by Application (2020-2025)
- 3.3.4 South America In-Vitro Diagnostics Market Size Breakdown by Application (2020-2025)
- 3.3.5 Middle East and Africa In-Vitro Diagnostics Market Size Breakdown by Application (2020-2025)
- 4 Global Market Dynamics
- 4.1 In-Vitro Diagnostics Industry Trends
- 4.2 In-Vitro Diagnostics Industry Drivers
- 4.3 In-Vitro Diagnostics Industry Opportunities and Challenges
- 4.4 In-Vitro Diagnostics Industry Restraints
- 5 Competitive Insights by Company
- 5.1 Global Top Players by In-Vitro Diagnostics Revenue (2020-2025)
- 5.2 Global In-Vitro Diagnostics Industry Company Ranking, 2023 VS 2024 VS 2025
- 5.3 Global In-Vitro Diagnostics Key Company Headquarters & Area Served
- 5.4 Global In-Vitro Diagnostics Company, Product Type & Application
- 5.5 Global In-Vitro Diagnostics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global In-Vitro Diagnostics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 In-Vitro Diagnostics Players Market Share by Revenue in 2024
- 5.6.3 2024 In-Vitro Diagnostics Tier 1, Tier 2, and Tier 3
- 6 Company Profiles
- 6.1 Roche
- 6.1.1 Roche Comapny Information
- 6.1.2 Roche Business Overview
- 6.1.3 Roche In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.1.4 Roche In-Vitro Diagnostics Product Portfolio
- 6.1.5 Roche Recent Developments
- 6.2 Siemens
- 6.2.1 Siemens Comapny Information
- 6.2.2 Siemens Business Overview
- 6.2.3 Siemens In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.2.4 Siemens In-Vitro Diagnostics Product Portfolio
- 6.2.5 Siemens Recent Developments
- 6.3 Abbott
- 6.3.1 Abbott Comapny Information
- 6.3.2 Abbott Business Overview
- 6.3.3 Abbott In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.3.4 Abbott In-Vitro Diagnostics Product Portfolio
- 6.3.5 Abbott Recent Developments
- 6.4 Danaher
- 6.4.1 Danaher Comapny Information
- 6.4.2 Danaher Business Overview
- 6.4.3 Danaher In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.4.4 Danaher In-Vitro Diagnostics Product Portfolio
- 6.4.5 Danaher Recent Developments
- 6.5 Thermo Fisher
- 6.5.1 Thermo Fisher Comapny Information
- 6.5.2 Thermo Fisher Business Overview
- 6.5.3 Thermo Fisher In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
- 6.5.5 Thermo Fisher Recent Developments
- 6.6 BioMerieux
- 6.6.1 BioMerieux Comapny Information
- 6.6.2 BioMerieux Business Overview
- 6.6.3 BioMerieux In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
- 6.6.5 BioMerieux Recent Developments
- 6.7 Bio-Rad
- 6.7.1 Bio-Rad Comapny Information
- 6.7.2 Bio-Rad Business Overview
- 6.7.3 Bio-Rad In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
- 6.7.5 Bio-Rad Recent Developments
- 6.8 BD
- 6.8.1 BD Comapny Information
- 6.8.2 BD Business Overview
- 6.8.3 BD In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.8.4 BD In-Vitro Diagnostics Product Portfolio
- 6.8.5 BD Recent Developments
- 6.9 JNJ
- 6.9.1 JNJ Comapny Information
- 6.9.2 JNJ Business Overview
- 6.9.3 JNJ In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.9.4 JNJ In-Vitro Diagnostics Product Portfolio
- 6.9.5 JNJ Recent Developments
- 6.10 Sysmex
- 6.10.1 Sysmex Comapny Information
- 6.10.2 Sysmex Business Overview
- 6.10.3 Sysmex In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
- 6.10.5 Sysmex Recent Developments
- 6.11 KHB
- 6.11.1 KHB Comapny Information
- 6.11.2 KHB Business Overview
- 6.11.3 KHB In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.11.4 KHB In-Vitro Diagnostics Product Portfolio
- 6.11.5 KHB Recent Developments
- 6.12 DaAn Gene
- 6.12.1 DaAn Gene Comapny Information
- 6.12.2 DaAn Gene Business Overview
- 6.12.3 DaAn Gene In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
- 6.12.5 DaAn Gene Recent Developments
- 6.13 Leadman
- 6.13.1 Leadman Comapny Information
- 6.13.2 Leadman Business Overview
- 6.13.3 Leadman In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.13.4 Leadman In-Vitro Diagnostics Product Portfolio
- 6.13.5 Leadman Recent Developments
- 6.14 BioSino
- 6.14.1 BioSino Comapny Information
- 6.14.2 BioSino Business Overview
- 6.14.3 BioSino In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.14.4 BioSino In-Vitro Diagnostics Product Portfolio
- 6.14.5 BioSino Recent Developments
- 6.15 BSBE
- 6.15.1 BSBE Comapny Information
- 6.15.2 BSBE Business Overview
- 6.15.3 BSBE In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.15.4 BSBE In-Vitro Diagnostics Product Portfolio
- 6.15.5 BSBE Recent Developments
- 6.16 Maccura
- 6.16.1 Maccura Comapny Information
- 6.16.2 Maccura Business Overview
- 6.16.3 Maccura In-Vitro Diagnostics Revenue, Global Share and Gross Margin (2020-2025)
- 6.16.4 Maccura In-Vitro Diagnostics Product Portfolio
- 6.16.5 Maccura Recent Developments
- 7 North America
- 7.1 North America In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2 North America In-Vitro Diagnostics Market Size by Country (2020-2025)
- 7.3 North America In-Vitro Diagnostics Market Size Forecast by Country (2026-2031)
- 8 Europe
- 8.1 Europe In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2 Europe In-Vitro Diagnostics Market Size by Country (2020-2025)
- 8.3 Europe In-Vitro Diagnostics Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2 Asia-Pacific In-Vitro Diagnostics Market Size by Country (2020-2025)
- 9.3 Asia-Pacific In-Vitro Diagnostics Market Size Forecast by Country (2026-2031)
- 10 South America
- 10.1 South America In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2 South America In-Vitro Diagnostics Market Size by Country (2020-2025)
- 10.3 South America In-Vitro Diagnostics Market Size Forecast by Country (2026-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2 Middle East & Africa In-Vitro Diagnostics Market Size by Country (2020-2025)
- 11.3 Middle East & Africa In-Vitro Diagnostics Market Size Forecast by Country (2026-2031)
- 12 Concluding Insights
- 13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
